GABAergic inhibition at symmetric synapses balances excitation, modulates the spike timing of various neurons, controls oscillatory network activities, and manages emerging properties in diverse neuronal circuits, which establish the basis for cognitive functions and behaviors (Klausberger and Somogyi, [@B6]; Buzsáki and Wang, [@B2]). To perform these diverse functions some interneurons form synapses exclusively on the dendrites of other neurons while others target the soma (Maccaferri, [@B11]; Freund and Katona, [@B4]). Therefore, it is reasonable to think that GABAergic synapses are heterogeneous, composed by recruiting various subunits of GABA~A~ receptors and their interacting proteins to form macromolecular complexes at the inhibitory synapses (Mann and Paulsen, [@B12]). Different types of GABAergic neurons also undergo dynamic changes during the early developmental period as well as in synaptic size and morphology, and these interneurons form or eliminate inhibitory synapses (Vogels et al., [@B16]; Antonelli et al., [@B1]; Flores and Méndez, [@B3]; Zacchi et al., [@B18]; Lu et al., [@B10]). Altered expressions and/or dysfunctions of several key interacting proteins of GABA~A~ receptors have been associated with schizophrenia, autism, epilepsy, mood disorders, Alzheimer\'s disease, and other neurological disorders caused by mutations, copy number variations, and single nucleotide polymorphisms (Ko et al., [@B7]).

Recently several studies reported growing numbers of proteins involved in inhibitory synapses (Kang et al., [@B5]; Loh et al., [@B9]; Nakamura et al., [@B14]; Uezu et al., [@B15]; Yamasaki et al., [@B17]). These molecules include ion channels, GPCRs, transporters, cytoskeletal proteins, adhesion proteins, signaling molecules including kinases and phosphatases, and ubiquitination-related proteins. Although it seems redundant to search for interacting proteins using different but closely related "bait" proteins, beside GABA~A~R subunits and their core binding proteins (e.g., gephyrin and neuroligin-2), proteins found at GABAergic synapses from these studies are distinct ones that lead us to speculate about their functional implications. First, by using transgenic mice with His6-FLAG-YFP tagging to Neuroligin-2, 76 proteins were identified as neuroligin-2 interacting proteins (Kang et al., [@B5]). Second, by using HRP-tagging to Neuroligin-2 and SLITRK3, 44 inhibitory synapse-specific proteins (vs. excitatory synapse-specific ones) including two synaptic orphan molecules (CSMD1/3 and CDH20) and MDGA2, were identified (Loh et al., [@B9]). Third, by using the Bio-ID tagging to gephyrin, 181 proteins were identified at the inhibitory postsynaptic density, which include ARHGEF9/Collybistin, Mena and Evl, IQSEC3, Px-RICS and two related proteins with unknown functions, InSyn1 and InSyn2 (Uezu et al., [@B15]). Interestingly, gephyrin, collybistin, and InSyn1 serve as three independent hub proteins that interact with different proteins at the inhibitory synapses (Uezu et al., [@B15]). Fourth, by using GFP and Myc epitope tagging of the α2 subunit of GABA~A~ receptors in transgenic mice, 174 proteins were identified as interacting proteins including cullin1, ephexin, KTDP12, mitofusin2, mGluR5, PAK7, and RAP5A (Nakamura et al., [@B14]).

Now, Yamasaki et al. used mass spectrometry to identify the GARLH protein family, GARLH4 (GABA~A~ receptor regulatory Lhfpl4) and GARLH3, as putative auxiliary subunits of GABA~A~Rs (Yamasaki et al., [@B17]). The search for these proteins of GABA~A~Rs was motivated on the report that the amplitude, but not the frequency, of miniature inhibitory postsynaptic currents (mIPSCs) was modestly decreased when gephyrin, a well-known GABA~A~R associated protein, was eliminated in neurons (Lévi et al., [@B8]). Therefore, it is speculated that gephyrin-independent, novel GABA~A~R-interacting proteins can be functioning at inhibitory synapses. GARLH4, in addition to the GABA~A~R γ2 subunit and neuroligin-2, is shown to be required to reconstitute the large GABA~A~R complex (720 kDa). Although direct interaction between GARLH4 and the GABA~A~R γ2 subunit is yet to be shown, Yamasaki et al., showed that GARLH4 stabilizes γ2-containing GABA~A~ receptors at inhibitory synapses and connects γ2 subunit and neuroligin-2. By using a transgenic mouse line (Gabra6-Cre), where gabrg2 was specifically deleted in cerebellar granule cells, it was found that levels of GARLH4 and neuroligin-2 were reduced. This indicates that γ2-containing GABA~A~ receptors stabilize GARLH4 protein expression in the cerebellum. In addition, the specific shRNA-mediated silencing of GARLH4 reduced clustering of γ2 GABA~A~R subunit, gephyrin, and neuroligin-2. In cultured hippocampal neurons, silencing of GARLH4 reduced the frequency, but not the amplitude, of mIPSC without affecting its decay kinetics compared to the one of mIPSCs of control neurons. In experiments using sgRNA-mediated deletion of GARLH4 in Cas9 knockin mice, the frequency, but not the amplitude of mIPSCs is decreased in acute hippocampal slice preparations as seen with cultured neurons. However, GARLH4 did not modulate the surface expression or sensitivity of agonists (GABA and THIP) and antagonist (picrotoxin) of α1β2γ2 GABA~A~Rs heterogeneously expressed in *Xenopus* oocytes. It is yet to be examined if the effects of allosteric modulators (e.g., benzodiazepines and neurosteroids) or other various combinations of GABA~A~R subunits (e.g., α1β3γ2 or α6β2γ2) are influenced in the presence of GARLH4.

GARLH4 and GARLH3 are likely to be four transmembrane proteins with both termini facing the cytosol. Therefore, there are possibilities of post-translational modification(s) or activity-dependent protein-protein interaction(s) of these two molecules. In addition, both have a putative ubiquitination residue (K9) at the N-terminal cytoplasmic domain ([www.phosphositeplus.org](http://www.phosphositeplus.org)). Since GARLH4 stabilizes GABA~A~ receptors at the synapse, it will be intriguing to see if and/or how GARLH4 plays a role in the activity-dependent plasticity of GABAergic synapses (Antonelli et al., [@B1]). GARLH4 and GARLH3 are particularly interesting because unlike most other GABA~A~R binding proteins, their expressions are region-specific (GARLH3-cerebellum and GARLH4- cerebellum and hippocampus). Thus, it might be suitable to elucidate the functions of these molecules by knocking out these molecules in a tissue specific manner. In addition, since GARLH3 has been implicated in primary glioblastoma, it may be interesting to see if and/or how GARLH3 displays the unknown contribution of inhibitory synapses to glioma or its *de novo* expression in glioma occurs without affecting GABAergic synaptic transmission (Milinkovic et al., [@B13]). Lastly, how does this GARLH4-GABA~A~-R association play a role early during development, in neurons with elevated \[Cl−\]~i~ (e.g., DRG neurons), or in diseased states when GABAergic activation is excitatory (e.g., epilepsy)? Now we have taken another exciting step in dissecting the specific roles of each molecule at the particular inhibitory synapses between unique combinations of neurons.
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